1-12 of 12
Craig I. Coleman, PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3673.
https://doi.org/10.1182/blood-2019-128581
Published: 2019
Journal Articles

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study

Craig I. Coleman, PharmD, Alexander G. Turpie, MD, Thomas J. Bunz, PharmD, PhD, Jan Beyer-Westendorf, MD, William L Baker, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1241.
https://doi.org/10.1182/blood-2018-99-114133
Published: 2018
Journal Articles

Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease

Craig I. Coleman, PharmD, Brandon K. Martinez, PharmD, Alexander G. G. Turpie, MD, Nitesh Sood, MD, Thomas J. Bunz, PharmD, PhD, Reinhold Kreutz, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2393.
https://doi.org/10.1182/blood.V130.Suppl_1.2393.2393
Published: 2017
Journal Articles

A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer

Jonathan Caranfa, PharmD, Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Nicole M. Kuderer, MD, Catherine Stirbis, BS, Mark Wysocki, PharmD, Craig I. Coleman, PharmD, Erin R Weeda, PharmD, Elaine Nguyen, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2105.
https://doi.org/10.1182/blood.V130.Suppl_1.2105.2105
Published: 2017
Journal Articles

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism

Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Jan Beyer-Westendorf, MD, Alex C. Spyropoulos, MD, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3717.
https://doi.org/10.1182/blood.V130.Suppl_1.3717.3717
Published: 2017
Journal Articles

Effectiveness and Safety of Rivaroxaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Known Primary Hypercoagulable States

Craig I. Coleman, PharmD, Alexander G. G. Turpie, MD, Thomas J. Bunz, PharmD, PhD, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1113.
https://doi.org/10.1182/blood.V130.Suppl_1.1113.1113
Published: 2017
Journal Articles

External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans

Neela K Kumar, MSPH, Erin R Weeda, PharmD, Philip S Wells, MD, Frank Peacock, MD, Gregory J Fermann, MD, Li Wang, MA, PhD MBA, Onur Baser, MS, PhD, Jeff Schein, DrPH, MPH, Crivera Crivera, PharmD, MPH, Craig I Coleman, PharmD, Christine G Kohn, PharmD
Journal: Blood
Blood (2016) 128 (22): 533.
https://doi.org/10.1182/blood.V128.22.533.533
Published: 2016
Journal Articles

Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status

Christine G Kohn, PharmD, Erin R Weeda, PharmD, W Frank Peacock, MD FACEP, Gregory J Fermann, MD, Christopher W. Baugh, MD MBA, Philip S Wells, MD FRCPC, MSc, Veronica Ashton, MPH, Concetta Crivera, PharmD, MPH, Peter Wildgoose, PhD, Jeff Schein, DrPH, MPH, Craig I Coleman, PharmD
Journal: Blood
Blood (2016) 128 (22): 2337.
https://doi.org/10.1182/blood.V128.22.2337.2337
Published: 2016
Journal Articles

External Validation of Generic and Cancer-Specific Risk Stratification Criteria for Predicting 30-Day Mortality in Patients Presenting with Pulmonary Embolism and Active Cancer

Jonathan T Caranfa, PharmD, Erin R Weeda, PharmD, Craig I Coleman, PharmD, Simon B. Zeichner, D.O., Christine G Kohn, PharmD
Journal: Blood
Blood (2016) 128 (22): 4730.
https://doi.org/10.1182/blood.V128.22.4730.4730
Published: 2016
Journal Articles

Validation of the Inhospital Mortality for Pulmonary Embolism Using Claims Data (IMPACT) Prediction Rule within an All-Payer Inpatient Administrative Claims Database

Craig I Coleman, PharmD, Christine G Kohn, PharmD, Concetta Crivera, Jeff Schein, W Frank Peacock, MD FACEP
Journal: Blood
Blood (2015) 126 (23): 747.
https://doi.org/10.1182/blood.V126.23.747.747
Published: 2015
Journal Articles

Does the Timing of Vital Sign Measurements Affect Simplified Pulmonary Embolism Severity Index (sPESI) Risk Determination?

Christine G Kohn, PharmD, Heather Rozjabek, MPH, Gregory J Fermann, MD, W Frank Peacock, MD FACEP, Concetta Crivera, Jeff Schein, Craig I Coleman, PharmD
Journal: Blood
Blood (2015) 126 (23): 2058.
https://doi.org/10.1182/blood.V126.23.2058.2058
Published: 2015
Journal Articles

Pulmonary Embolism Begets Pulmonary Embolism?: A Meta-Analysis Depicting the Type of Recurrence Following an Index Pulmonary Embolism

Craig I Coleman, PharmD, Christine G Kohn, PharmD, Dhaval Patel, BS
Journal: Blood
Blood (2014) 124 (21): 4832.
https://doi.org/10.1182/blood.V124.21.4832.4832
Published: 2014